MERS-CoV (Nucleoprotein)
Description
| Amount: | 25 ??g (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) |
|---|---|
| Application: | T-cell immunity |
| Category: | PepMix Peptide Pools |
| Condition / Topic: | Infection, Middle Eastern Respiratory Syndrome (MERS) |
| Layout: | Freeze-dried in glass vial |
| Organism: | MERS-CoV (Middle East respiratory syndrome-related coronavirus) |
| Protein Name: | Nucleoprotein |
| Purity: | Development Grade: each peptide purified to > 70% (HPLC/MS) |
| Quantification: | No |
|
Sequence: |
MASPAAPRAVSFADNNDITNTNLSRGRGRNPKPRAAPNNTVSWYTGLTQHGKVPLTFPPGQGVPLNANSTPAQNAGYWRRQDRKINTGNGIKQLAPRWYFYYTGTGPEAALPFRAVKDGIVWVHEDGATDAPSTFGTRNPNNDSAIVTQFAPGTKLPKNFHIEGTGGNSQSSSRASSVSRNSSRSSSQGSRSGNSTRGTSPGPSGIGAVGGDLLYLDLLNRLQALESGKVKQSQPKVITKKDAAAAKNKMRHKRTSTKSFNMVQAFGLRGPGDLQGNFGDLQLNKLGTEDPRWPQIAELAPTASAFMGMSQFKLTHQNNDDHGNPVYFLRYSGAIKLDPKNPNYNKWLELLEQNIDAYKTFPKKEKKQKAPKEESTDQMSEPPKEHRVQGTQRTRTRPSVQPGPMIDVNTD
|
|---|---|
|
Specifications: |
Peptide scan (15mers with 11 aa overlap) |
